A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Conditions
- Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Interventions
- DRUG: NS-863 Low Dose
- DRUG: NS-863 High Dose
- OTHER: Placebo
Sponsor
NS Pharma, Inc.
Collaborators